MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
25.88
-0.05
-0.19%
After Hours: 25.88 0 0.00% 19:34 07/24 EDT
OPEN
25.91
PREV CLOSE
25.93
HIGH
26.04
LOW
25.37
VOLUME
425.45K
TURNOVER
--
52 WEEK HIGH
27.64
52 WEEK LOW
18.80
MARKET CAP
1.02B
P/E (TTM)
207.04
1D
5D
1M
3M
1Y
5Y
1D
Pacira Biosciences to report Q2 2026 results, host conference call
PUBT · 3d ago
Weekly Report: what happened at PCRX last week (0713-0717)?
Weekly Report · 5d ago
Weekly Report: what happened at PCRX last week (0706-0710)?
Weekly Report · 07/13 09:16
Pacira BioSciences (PCRX) Wins Broader EXPAREL Reimbursement, Is The Stock Still Undervalued?
Simply Wall St · 07/08 12:33
Pacira grants inducement stock awards to new hires, sets options exercise price at $25.39
PUBT · 07/08 12:01
PACIRA BIOSCIENCES REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 07/08 12:00
How Investors Are Reacting To Pacira BioSciences (PCRX) Winning Broader EXPAREL Reimbursement From UnitedHealthcare
Simply Wall St · 07/07 09:25
Weekly Report: what happened at PCRX last week (0629-0703)?
Weekly Report · 07/06 09:17
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.